ArticleTherapeutic advances in medical oncology2021

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.

Candice Hober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.